Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in

Action Potential Venture Capital

WebsiteLinkedIncbCrunchbase
Status
ACTIVE
Global HQ
Scotts Valley, USA
Countries of investment
  • USA
  • Canada
Investment stages
  • Seed
  • Series A
  • Series B
Industries
  • Health Tech
  • Biotechnology
  • Pharmaceuticals
  • Medical Devices
  • Digital Health
About
Action Potential Venture Capital (APVC) is a leading medtech venture capital firm founded by GSK in 2013. APVC invests globally in startups advancing bioelectronic medicines and enabling technologies. They actively support innovation in neural interfacing and electroceuticals.
Min check size
$100K
Max check size
$30M
Fund size
NPS

Investment Thesis

APVC is dedicated to bringing bioelectronic medicines to patients by supporting innovators and entrepreneurs pioneering a bioelectronic future.
Lead investor
Co Invest
Number of exits
Preferred contact method

Action Potential Venture Capital Contacts Information

Primary contact

Secondary contact

Portfolio

Alpheus Medical

Cala Health

CVRx

Exo Imaging

MicroTransponder

Neuspera

Onc AI

Presidio Medical

Saluda Medical

SetPoint Medical.

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp